SELLAS Life Sciences Group, Inc. (SLS)
(Delayed Data from NSDQ)
$1.59 USD
-0.03 (-1.85%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.58 -0.01 (-0.63%) 4:38 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
SELLAS Life Sciences Group, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SLS 1.59 -0.03(-1.85%)
Will SLS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SLS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLS
SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised)
Galena Biopharma (SLS) Upgraded to Buy: What Does It Mean for the Stock?
SLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Galena Biopharma (SLS) Upgraded to Buy: Here's Why
Other News for SLS
Vanguard Group Inc's Strategic Acquisition in SELLAS Life Sciences Group Inc
Maxim Increases Price Target for Sellas Life Sciences (SLS) | SLS Stock News
Sellas Life Sciences price target raised by $3 at Maxim, here's why
SLS Stock: Maxim Group Raises Price Target by 75% to $7.00 | SLS Stock News
SELLAS Life Sciences (SLS) Rises on Promising AML Trial Results